Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Royalty Pharma Q2 Sales $555.00M Beat $483.42M Estimate

Royalty Pharma (NASDAQ:RPRX) reported quarterly sales of $555.00 million which beat the analyst consensus estimate of $483.42 million by 14.81 percent. This is a 8.61 percent increase over sales of $511.00 million the

byBill Haddad

August 11, 2021

1 minute read

Royalty Pharma (NASDAQ:RPRX) reported quarterly sales of $555.00 million which beat the analyst consensus estimate of $483.42 million by 14.81 percent. This is a 8.61 percent increase over sales of $511.00 million the same period last year.